pigs with sacrifice at 28 days. Endpoints were assessed by quantitative coronary angiog raphy @CA), histomorphometry, and histology at 28 and 90 days. Results:There was reduction of intimal hyperplasia as assessed by QCA and histomorphometry by both E and S (Table 1) . At both 28 and 90 days, there was complete reendothelialization and ho difference in inflammation or fibrin between the bare stent and druglpolymer groups.
Conclusion:
Everolimus and Sirolimus delivered via stent and thin layer biodegradable polymer are equally effective at inhibition of intimal hyperplasia. At follow-up evaluation. complete healing without toxic or inflammatory reaction was seen. A clinical trial to determine safety and efficacy of the Everolimus coated stent has commenced. with A24 (10 w/mm). Fifteen pigs underwent placement of oversized bare metal (n = 15) polymer (n = 8) and A24 (n = 9) stents in the coronary arteries.
Results:
At 28-days. histology demonstrated similar mean injury scores for the control, polymer and A24 coated stents. The mean neointimal area (mm*) was significantly reduced for A24 (1.70 f 0.47) as compared with polymer (2.82 f 1.24) and control (2.89 f 1.91) stents (p c 0.005). The 40% reduction in neointimal area resulted in significantly less mean percent diameter stenosis for A24 (19.4 f 4.0 %) as compared with polymer (30.3 * 12.1 %), and control (29.4 * 15.5 %) stents (p < 0.001). Twelve of the 45 bare metal stent cross sections exhibited a giant cell reaction while none of the 26 sections from the A24 stems had a giant cell response.
Concfusions:
Stent-based delivery of A24 inhibits neointimal formation and the inflammatory response to the prosthesis in the porcine coronary model. Further study IS necessary to determine the dose-response and long-term effects A24 eluting stents in the porcine coronary model. 
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First-in-Human Study of Angiopeptin-Eluting Stents: A Quantitative Coronary Angiography and Volumetric Intravascular Ultrasound Study
France
Titanium nitride oxyde (Ti-NO) is biologically inert has an excellent biocompatibility exemplified by the lack of a redox and hydrolysis reaction as well as an absent complex metal ion-organic molecule binding formation. Ti-NO coated stent has significantly reduced neointimal proliferation compared to stainless steel stent in pigs. The aim of our study was to prospectively evaluate the feasibility and safety of a Ti-NO stainless steel coated stem (Helistent @, Hexacath, France) in humans.
Inclusion criteria were a single lesion less than15 mm in length in a native coronary artery with a reference diameter between 3.0 and 4.0 mm eligible for PCI. Exclusion criteria were high-grade calcifications, ostial or bifurcation lesion, less than 72 hours acute myocardial infarction. Clinical follow-up was performed at one month and angiographic fol- Renal artery stenosis (RAS) is an important cause of hypertension and ischemic renal disease and should be identified in patients (pts) where possible. Data on the predictive risk of RAS at the time of coronary angiography for different patient profiles is lacking. Our aim was to determine the incidence of RAS in a large group of pts undergoing coronary angiography and to develop a model to determine the risk of RAS for any subgroup of pts. Methods: A total of 2111 consecutive pts were screened for RAS with a contrast injection in the descending aorta after the ventriculogram. Multiple risk factors were assessed. Results: RAS was present in 1% of pts without CAD and in 13% of pts with CAD. Independent risk factors for RAS in pts with CAD were age (Odds ratio (OR) l.O5/year, p<O.OOl), female sex (OR 1.91, p<O.OOl), peripheral vascular disease (PVD) (OR 2.32, p<O.OOl), cerebrovascular disease (CVD) (OR 1.60, p&05), 3 vessel disease (OR 3.14. p<O.OOl) and hypertension (OR 1.56, p=O.Ol). A model was developed utllizing these risk factors which enables the prediction of RAS in different patient profiles. An example is shown for males aged 60 with hypertension and CAD. Conclusions: RAS was rare in pts without CAD. In pts with CAD, there was a relatively high Incidence of unsuspected RAS (13%). In pts with CAD and RAS there was a high incidence of other vascular disease. The incidence of RAS in pts with CAD can be predicted using the model developed and may aid in determining which pts should be screened.
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